Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial).

Institutions Share
National Research Center for Translational Medicine, China 0.17
Shanghai Institute of Hematology at Ruijin Hospital, SJTU, China 0.17
Fujian Medical University Union Hospital, China 0.04
The First Affiliated Hospital of Soochow University, China 0.04
West China School of Medicine/West China Hospital of Sichuan University (WCSM/WCH), SCU, China 0.04
Clinical Research Center, China 0.04
First Affiliated Hospital, ZJU, China 0.04
Wuhan Union Hospital, HUST, China 0.04
Nanfang Hospital, China 0.04
The First Hospital of China Medical University, China 0.04
Tongji Hospital (TJH), HUST, China 0.04
The Second Hospital of Dalian Medical University, DMU, China 0.02
Peking University People's Hospital, China 0.02
Qilu Hospital of Shandong University, China 0.02
Tangdu Hospital, China 0.02
Ningbo No.1 Hospital, ZJU, China 0.02
Guangdong Academy of Medical Sciences (Guangdong General Hospital), China 0.02
First Affiliated Hospital, AHMU, China 0.02
Shandong Provincial Hospital, China 0.02
Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University), China 0.02
The First Affiliated Hospital, SYSU, China 0.02
The First Affiliated Hospital of Guangxi Medical University, China 0.02
Southwest Hospital, Army Medical University, China 0.02
Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, China 0.02
Ruijin Hospital, SJTU, China 0.01

Return